N-methyladenosine (mA) is the most abundant internal modification on eukaryotic mRNAs. Demethylation of mA on mRNA is catalyzed by the enzyme fat mass and obesity-associated protein (FTO), a member of the nonheme Fe(II) and 2-oxoglutarate (2-OG)-dependent family of dioxygenases. FTO activity and mA-mRNA are dysregulated in multiple diseases including cancers, yet endogenous signaling molecules that modulate FTO activity have not been identified. Here we show that nitric oxide (NO) is a potent inhibitor of FTO demethylase activity by directly binding to the catalytic iron center, which causes global mA hypermethylation of mRNA in cells and results in gene-specific enrichment of mA on mRNA of NO-regulated transcripts. Both cell culture and tumor xenograft models demonstrated that endogenous NO synthesis can regulate mA-mRNA levels and transcriptional changes of mA-associated genes. These results build a direct link between NO and mA-mRNA regulation and reveal a novel signaling mechanism of NO as an endogenous regulator of the epitranscriptome.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623363 | PMC |
http://dx.doi.org/10.1016/j.redox.2023.102928 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!